<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04262479710699</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA1030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:51:35.421Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710705</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:51:34.820Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710712</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:51:21.241Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710729</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:50:37.436Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710736</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:50:12.491Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710743</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:50:05.098Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710750</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:49:49.749Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710767</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA2030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:49:22.721Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710774</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:52.047Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710781</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:42.984Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710798</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>Q02030301</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:39.564Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710804</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:15.865Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710811</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:12.788Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710828</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:05.620Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710835</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>LUCIDUS HA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LUCA3030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:05.189Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710972</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:48:04.750Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710989</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:15.338Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710996</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:15.225Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711009</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:15.114Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479711016</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>VISCO HYL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VISA1018</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-04T19:47:07.263Z</lastUpdated>
  </row>
</eudamedExport>